Literature DB >> 18848788

Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer.

John P Stein1, Richard E Hautmann, David Penson, Donald G Skinner.   

Abstract

PURPOSE: The standard treatment of high-grade, invasive bladder cancer is radical cystectomy. Prostate-sparing techniques have recently become an alternative surgical approach for the treatment of the disease. We review the literature regarding the oncologic and functional outcomes for prostate-sparing approaches.
MATERIALS AND METHODS: The literature pertaining to prostate-sparing cystectomy was reviewed. The oncologic issues of preserving the prostate in patients undergoing cystectomy for bladder cancer along with the functional outcomes were evaluated.
RESULTS: There is a significant incidence of bladder and prostate cancer involving the prostate, and prostate apex in men requiring cystectomy for transitional cell carcinoma of the bladder at the time of surgery. This involvement of the prostate with cancer maybe difficult to determine preoperatively. Importantly, although prostate-sparing procedures provide good potency results, the functional outcomes following cystectomy and orthotopic diversion to the urethra are not significantly different, particularly regarding daytime continence. Lastly, several studies suggest the oncologic outcomes following prostate-sparing cystectomy may be compromised with this surgical approach.
CONCLUSIONS: The significant incidence of bladder and prostate cancer involving the prostate at the time of cystectomy, which is difficult to determine preoperatively, may preclude the general application of prostate-sparing techniques in most men requiring cystectomy. Concerns regarding the oncologic outcomes with prostate-sparing techniques, coupled with the excellent results seen with traditional radical cystectomy and orthotopic diversion, suggest that prostate-sparing procedure should be performed only in well-selected individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18848788     DOI: 10.1016/j.urolonc.2007.12.014

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  7 in total

Review 1.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

Review 2.  Sexual dysfunction after cystectomy and urinary diversion.

Authors:  Rishi A Modh; John P Mulhall; Scott M Gilbert
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

3.  Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.

Authors:  R Colombo; F Pellucchi; M Moschini; A Gallina; R Bertini; A Salonia; P Rigatti; F Montorsi
Journal:  World J Urol       Date:  2015-01-11       Impact factor: 4.226

Review 4.  Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.

Authors:  Bernhard Kiss; Fiona C Burkhard; George N Thalmann
Journal:  World J Urol       Date:  2015-11-19       Impact factor: 4.226

5.  Comparisons of Quality of Life and Functional and Oncological Outcomes after Orthotopic Neobladder Reconstruction: Prostate-Sparing Cystectomy versus Conventional Radical Cystoprostatectomy.

Authors:  Po Yen Chen; Po Hui Chiang
Journal:  Biomed Res Int       Date:  2017-05-15       Impact factor: 3.411

6.  Prostate-sparing cystectomy: Potential functional advantages and objective oncological risks; a case series and review.

Authors:  Hani Nour; Omar Abdelrazak; Mohamed Wishahy; Seif Elkatib; Henry Botto
Journal:  Arab J Urol       Date:  2011-09-10

7.  Prostate sparing cystectomy: A procedure with limited indications.

Authors:  Ramy F Youssef
Journal:  Arab J Urol       Date:  2011-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.